Results 111 to 120 of about 8,373 (204)

A case of pulmonary transthyretin amyloidosis with concurrent mycobacterial tuberculosis infection

Respirology Case Reports
Amyloidosis is a pathological deposition disease that causes a spectrum of organ dysfunction. Pulmonary involvement is generally associated with immunoglobulin light chain type (AL) amyloid. Transthyretin (ATTR) amyloid build up in the lung is thought to
Hanson Siu, Ari Mond, James Shaw, Ruth Chin, Patrick Hosking, Hari Wimaleswaran   +5 more
doaj   +1 more source

The role of palliative care in the multidisciplinary treatment of immunoglobulin light chain amyloidosis [PDF]

Pedro Vianna, Joshua Lakin, Samantha Gelfand, Eilann Santo, Brigitte Durieux, Shannon Miller, Shahrier Hossain, Jacob Laubach, Giada Bianchi   +8 more
openalex   +1 more source

Beyond the plasma cell: emerging therapies for immunoglobulin light chain amyloidosis [PDF]

, 2016
Brendan M. Weiss, Sandy W. Wong, Raymond L. Comenzo   +2 more
openalex   +1 more source

The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation [PDF]

, 2015
Nelson Leung, Shaji Kumar, Siobhán Glavey, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, David Dingli, Prashant Kapoor, Steven R. Zeldenrust, Stephen J. Russell, John A. Lust, William J. Hogan, S. Vincent Rajkumar, Dennis A. Gastineau, Taxiarchis Kourelis, Yi Lin, Wilson I. Gonsalves, Ronald S. Go, Morie A. Gertz   +19 more
openalex   +1 more source

Amyloid cranial polyneuropathy: A rare neurological presentation of immunoglobulin light-chain amyloidosis. [PDF]

Aging Med (Milton), 2021
Agarwal A, Paul Wilson B, Kuruvilla Mathews P, Viggeswarpu S, Kango Gopal G.   +4 more
europepmc   +1 more source

Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis [PDF]

, 2015
Sami Safadi, Ahmed Saad, Patrick Quint, Sanjeev Sethi, Nelson Leung, Paul J. Kurtin, Samih H. Nasr   +6 more
openalex   +1 more source

Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives

Journal of Blood Medicine, 2019
Shayna Sarosiek, Vaishali Sanchorawala Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, MA, USACorrespondence: Shayna Sarosiek; Vaishali SanchorawalaAmyloidosis Center, Boston University School of Medicine and ...
Sarosiek S, Sanchorawala V
doaj  

T cell landscape and dynamics in immunoglobulin light chain amyloidosis before and after daratumumab-based therapy. [PDF]

Clin Transl Med, 2021
Wang Y, Xu L, Zhao W, Chen X, Wen L, Duan W, Yu XJ, De Zhou F, Liu Y, Hao J, Huang X, Lu J, Ge Q.   +12 more
europepmc   +1 more source

Clinical characteristics and prognosis of immunoglobulin light chain amyloidosis patients [PDF]

Lijun Song, Su Yan, Rong Li, Siyi Du, Yimiao Xue, Yihai Gu, J. Chen, Xing Xing, Ziyuan Shen, Yuping Wei   +9 more
openalex   +1 more source

Clonal immunoglobulin light chain variable region germline gene use in AL amyloidosis: association with dominant amyloid‐related organ involvement and survival after stem cell transplantation [PDF]

, 1999
Raymond L. Comenzo, Jeremy Wally, Geraldina Kica, Jessica E. Murray, Thomas Ericsson, Martha Skinner, Yana Zhang   +6 more
openalex   +1 more source